We just received data on a new analyst forecast for $CHTR. Keybanc gave a rating of 'Sector Weight' for $CHTR.
$CHTR Analyst Ratings
Wall Street analysts have issued reports on $CHTR in the last several months. We have seen 4 firms issue buy ratings on the stock, and 2 firms issue sell ratings.
Here are some recent analyst ratings:
- Citigroup issued a "Buy" rating on 10/06/2025
- B of A Securities issued a "Buy" rating on 09/24/2025
- Bernstein issued a "Outperform" rating on 09/10/2025
- Goldman Sachs issued a "Sell" rating on 09/02/2025
- Barclays issued a "Underweight" rating on 07/28/2025
- Loop Capital issued a "Buy" rating on 05/19/2025
To track analyst ratings and price targets for $CHTR, check out Quiver Quantitative's $CHTR forecast page.
$CHTR Price Targets
Multiple analysts have issued price targets for $CHTR recently. We have seen 10 analysts offer price targets for $CHTR in the last 6 months, with a median target of $352.5.
Here are some recent targets:
- Michael Rollins from Citigroup set a target price of $325.0 on 10/06/2025
- Brandon Nispel from Keybanc set a target price of $430.0 on 10/03/2025
- Jessica Ehrlich from B of A Securities set a target price of $355.0 on 09/24/2025
- Laurent Yoon from Bernstein set a target price of $350.0 on 09/10/2025
- Michael Ng from Goldman Sachs set a target price of $223.0 on 09/02/2025
- Steven Cahall from Wells Fargo set a target price of $300.0 on 08/21/2025
- John Hodulik from UBS set a target price of $355.0 on 07/28/2025
$CHTR Congressional Stock Trading
Members of Congress have traded $CHTR stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CHTR stock by members of Congress over the last 6 months:
- REPRESENTATIVE JEFFERSON SHREVE sold up to $50,000 on 05/12.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CHTR Insider Trading Activity
$CHTR insiders have traded $CHTR stock on the open market 3 times in the past 6 months. Of those trades, 2 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CHTR stock by insiders over the last 6 months:
- CHRISTOPHER L WINFREY (President and CEO) purchased 3,670 shares for an estimated $1,002,258
- RICHARD J DIGERONIMO (President-Product & Technology) sold 1,551 shares for an estimated $657,321
- BALAN NAIR purchased 360 shares for an estimated $98,715
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CHTR Hedge Fund Activity
We have seen 403 institutional investors add shares of $CHTR stock to their portfolio, and 442 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL RESEARCH GLOBAL INVESTORS removed 1,626,990 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $665,129,781
- BERKSHIRE HATHAWAY INC removed 923,377 shares (-46.5%) from their portfolio in Q2 2025, for an estimated $377,485,751
- BLACKROCK, INC. added 910,571 shares (+13.1%) to their portfolio in Q2 2025, for an estimated $372,250,530
- ROYAL BANK OF CANADA added 782,067 shares (+446.7%) to their portfolio in Q2 2025, for an estimated $319,716,810
- CITADEL ADVISORS LLC removed 637,603 shares (-39.9%) from their portfolio in Q2 2025, for an estimated $260,658,482
- HARRIS ASSOCIATES L P removed 469,692 shares (-11.3%) from their portfolio in Q2 2025, for an estimated $192,014,786
- FMR LLC added 410,681 shares (+38.8%) to their portfolio in Q2 2025, for an estimated $167,890,499
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
